Showing 3821-3830 of 4063 results for "".
- Eyeris Announces Industry-First, Environmentally-Conscious Packaginghttps://modernod.com/news/eyeris-announces-industry-first-environmentally-conscious-packaging/2476959/Nashville-based start-up Eyeris recently announced its daily disposable contact lens that will be launching in January of 2020. Along with the lens, Eyeris created industry-first trial lens packa
- Johnson & Johnson Vision Launches Worldwide #ConnectedBySight Campaign in Honor of World Sight Dayhttps://modernod.com/news/johnson-johnson-vision-launches-worldwide-connectedbysight-campaign-in-honor-of-world-sight-day/2476949/In honor of World Sight Day on October 10, 2019, Johnson & Johnson Vision has launched a worldwide campaign to share the untold stories of eye care professionals, patients, and organizations who are inspiring the elevation of eye health as a global priority and demonstrating how the world is
- EyePoint Pharmaceuticals Announces Permanent and Specific J-Code for Yutiq Now in Effecthttps://modernod.com/news/eyepoint-pharmaceuticals-announces-permanent-and-specific-j-code-for-yutiq-now-in-effect/2476934/EyePoint Pharmaceuticals announced that the company’s permanent and specific J-Code for Yutiq (fluocinolone acetonide intravitreal implant) 0.18 mg 3-year microinsert for chronic, noninfectious uveitis affecting the posterior segment of the eye is now in effect. The code, J7314, was issued by the
- EyeCarePro Acquires the Optometrists Networkhttps://modernod.com/news/eyecarepro-acquires-the-optometrists-network/2476917/As part of an overall business strategy of expanding services for optometric medical specializations, EyeCarePro acquired the assets belonging to the Optometrists Network in July 2019, according to a report in VisionMonday. These include the related networks of vision therapy and neuro-opt
- Carl Zeiss AG Names New President and CEOhttps://modernod.com/news/carl-zeiss-ag-names-new-president-and-ceo/2476913/At its meeting on September 24, the Supervisory Board of Carl Zeiss AG unanimously voted in favor of the following changes to the Executive Board: Dr. Karl Lamprecht, currently a member of the Executive Board, will become the new President & CEO effective April 1, 2020. Dr. Karl Lamprecht wil
- Konan Medical’s EyeKinetix Pupillograph is Now Available in the United Stateshttps://modernod.com/news/konan-medicals-eyekinetix-pupillograph-is-now-available-in-the-united-states/2476902/Konan Medical announced that EyeKinetix is FDA listed and now available for sale in the United States. EyeKinetix is Konan’s 2nd generation pupillograph, which is smaller, faster, easier to use and less expensive than its predecessor, RAPDx, a device that brought key pupillary testin
- Graybug Vision Initiates Clinical Trial in Macular Edema Secondary to DME or RVOhttps://modernod.com/news/graybug-vision-initiates-clinical-trial-in-macular-edema-secondary-to-dme-or-rvo/2476898/Graybug Vision announced the initiation of its phase 2a study with GB-102 in patients with macular edema (ME) secondary to diabetic macular edema (DME) or retinal vein occlusion (RVO). GB-102, a pan-Vascular Endothelial Growth Factor (VEGF) inhibitor and potential twice-per-year therapy is
- Nicox Provides Business Update and Upcoming Milestoneshttps://modernod.com/news/nicox-provides-business-update-and-upcoming-milestones/2476887/Nicox SA reported the financial results for Nicox and its subsidiaries for the 6 months ending June 30, 2019 and provided an update on its activities as well as key upcoming milestones. “This is a compelling and potentially transformative time for Nicox, as we make strong progress in our g
- Zeiss to Showcase Advancements in Digital and Surgical Technology at ESCRShttps://modernod.com/news/zeiss-to-showcase-advancements-in-digital-and-surgical-technology-at-escrs/2476881/During the 2019 European Society of Cataract and Refractive Surgery (ESCRS) annual meeting in Paris, Zeiss will p
- SightGlass Vision to Present Pivotal Clinical Trial Baseline Data Evaluating Novel Lenses to Control Nearsightedness in Childrenhttps://modernod.com/news/sightglass-vision-to-present-pivotal-clinical-trial-baseline-data-evaluating-novel-lenses-to-control-nearsightedness-in-children/2476876/SightGlass Vision announced that baseline data from CYPRESS, the company’s pivotal trial assessing the safety and efficacy of novel lenses designed to control nearsightedness in children, will be presented at the 17th International Myopia Conference 2019, held